Metabolic syndrome in HIV-infected individuals: underlying mechanisms and epidemiological aspects

Table 2 MetS prevalences among different HIV populations

MetS criteria	Prevalence (%)	Remarks	Reference/year
NCEP-ATP III	45.4	n = 553, Italy.	[21]/2002
	45.4	On HAART	[21]/2002
	17	n = 710, Spain.	[22]/2005
	22	n = 1243 Italy.	[23]/2006
	22	SIMONE multicenter study	[23]/2006
	15.8	n = 146, Spain Madrid.	[24]/2006
	15.8	On HAART, plus 159 HIV negative patients matched by BMI	[24]/2006
	18	n = 788.	[25]/2007
	18	Lipodystrophy case definition cohort (international multicenter)	[25]/2007
	25.5	n = 471, USA.	[26]/2007
	25.5	NHANES, matched for age, gender, ethnicity, tobacco use	[26]/2007
	20.8	n = 1243, Italy.	[25]/2007
	20.8	SIMONE multicenter study	[25]/2007
EGIR	39.8	n = 201, Italy.	[27]/2002
	39.8	On HAART.	[27]/2002
	33.1	n = 287, Italy.	[28]/2003
	33.1	On HAART	[28]/2003
NHLBI	24	n = 77, USA.	[20]/2006
NHLBI	24	NFHL Study	[20]/2006
IDF	14	n = 788.	[25]/2007
	14	Lipodystrophy case definition cohort (international multicenter)	[25]/2007
	11.4	n = 210, Spain.	[29]/2007

ISSN: 1742-6405